市場調查報告書

全球躁鬱症市場:2019-2025

Global Bipolar Disorder Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 949385
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球躁鬱症市場:2019-2025 Global Bipolar Disorder Market 2019-2025
出版日期: 2020年05月12日內容資訊: 英文
簡介

在預測期間,預計全球雙相情感障礙市場將顯著增長。市場增長的主要驅動力包括對心理健康的要求增加,工作場所壓力的增加以及全世界對心理健康的意識增強。預計歐洲將在全球市場中佔有很大份額。該地區人口眾多,患有精神疾病,如焦慮症和抑鬱症,這推動了歐洲雙相情感障礙市場的增長。除此之外,精神健康和先進醫療系統資源的可利用性和可利用性是有望在不久的將來推動市場增長的重要因素。

本報告調查和分析了全球雙相情感障礙市場,市場概況,影響市場增長的因素,市場規模和預測,按細分市場的分析,按地區/國家進行的市場分析,競爭情況等。

內容

第1章報告概述

第2章市場概述和討論

  • 調查範圍
  • 分析師見解和當前市場趨勢
  • 規則與規定

第3章競爭情況

  • 公司佔有率分析
  • 主要策略分析
  • 主要公司分析
    • Allergan PLC
    • Otsuka Pharmaceutical Co., Ltd.
    • Johnson&Johnson Services、Inc.
    • Eli Lilly and Co.
    • AstraZeneca PLC

第4章市場決定因素

  • 促進要因
  • 抑制因子
  • 機會

第5章市場細分

  • 全球雙相情感障礙市場的類型
    • I型雙相情感障礙
    • II型雙相情感障礙
  • 全球雙相情感障礙市場(按治療)
    • 藥物
    • 療法和設備/應用
  • 全球雙相情感障礙市場的作用機理
    • 選擇性5-羥色胺再攝取抑製劑(SSRI)
    • 血清素/去甲腎上腺素再攝取抑製劑(SNRI)
    • 苯二氮卓類
    • Beta受體阻滯劑
    • 其他(三環抗抑鬱藥(TCA))

第6章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第7章公司簡介

  • Abbott Laboratories
  • AbbVie Inc.
  • Alkermes PLC
  • Allergan PLC
  • AstraZeneca PLC
  • Brainsway Ltd.
  • Bristol-Myers Squibb Co.
  • Eli Lilly and Co.
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Inexika Inc.
  • Johnson & Johnson Services, Inc.
  • Lupin Ltd.
  • Mood Tracker Web Media, LLC
  • Neuronetics, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Proteus Digital Health, Inc.
  • Sunovion Pharmaceuticals Inc.
目錄
Product Code: OMR2021703

Global Bipolar Disorder Market Size, Share & Trends Analysis Report by Type (Bipolar Disorder I and Bipolar Disorder II, and Others), by treatment (Drugs & Medications and Therapy & Devices/Apps) and by Mechanism of Action (Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIS), Benzodiazepines, Beta Blockers, and Others) and Forecast 2019-2025

The global bipolar disorder market is projected to witness considerable growth during the forecast period. The major factors contributing to the growth of the market include the growing insurance claims for mental health, increased levels of stress at the workplace, and rising awareness regarding metal health across the globe. Based on type, the market is segmented into bipolar disorder I, bipolar disorder II, and others. Based on the treatment, the market is bifurcated into drugs & medications and therapy & devices/apps. The drugs & medications segment is further segmented into anticonvulsants, antidepressants, antipsychotics, and others. Based on mechanism of action, the market is segmented into selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), benzodiazepines, beta blockers, and others.

Geographically, the global bipolar disorder market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. Europe is expected to contribute a significant share in the global market. The region has a significant population with mental health disorders, such as anxiety and depression, which in turn, is driving the growth of the bipolar disorder market in Europe. Along with this, the availability of considerable resources for mental health and sophisticated healthcare system are other key factors that are expected to promote the growth of the market in the near future. In UK, Mental Health First Aid (MHFA) England, a social organization that offers expert guidance and training to support mental health, estimated in 2019 that nearly one in four people face mental health issues each year and are responsible for 72 million working days lost and costs $45.5 billion each year.

The global bipolar disorder market is influenced by product development and advancements conducted by the market players. The key players of the bipolar disorder market include Allergan PLC, Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Co., AstraZeneca PLC, and Johnson & Johnson Services, Inc. These players are playing a significant role in the growth of the bipolar disorder market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the global bipolar disorder market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Bipolar Disorder Market Research and Analysis by Type

2. Global Bipolar Disorder Market Research and Analysis by Treatment

3. Global Bipolar Disorder Market Research and Analysis by Mechanism of Action

The Report Covers:

  • Comprehensive research methodology of the global bipolar disorder market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global bipolar disorder market.
  • Insights about market determinants which are stimulating the global market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Allergan PLC
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Otsuka Pharmaceutical Co., Ltd.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Johnson & Johnson Services, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Eli Lilly and Co.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. AstraZeneca PLC
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Bipolar Disorder Market by Type
    • 5.1.1. Bipolar Disorder I
    • 5.1.2. Bipolar Disorder II
    • 5.1.3. Others (Cyclothymic Disorder)
  • 5.2. Global Bipolar Disorder Market by Treatment
    • 5.2.1. Drugs & Medications
      • 5.2.1.1. Anticonvulsants
      • 5.2.1.2. Antidepressants
      • 5.2.1.3. Antipsychotics
      • 5.2.1.4. Others (Mood Stabilisers)
    • 5.2.2. Therapy & Devices/Apps
  • 5.3. Global Bipolar Disorder Market by Mechanism of Action
    • 5.3.1. Selective Serotonin Reuptake Inhibitors (SSRIs)
    • 5.3.2. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
    • 5.3.3. Benzodiazepines
    • 5.3.4. Beta Blockers
    • 5.3.5. Others (Tricyclic Antidepressants (TCAs))

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. AbbVie Inc.
  • 7.3. Alkermes PLC
  • 7.4. Allergan PLC
  • 7.5. AstraZeneca PLC
  • 7.6. Brainsway Ltd.
  • 7.7. Bristol-Myers Squibb Co.
  • 7.8. Eli Lilly and Co.
  • 7.9. GlaxoSmithKline PLC
  • 7.10. H. Lundbeck A/S
  • 7.11. Inexika Inc.
  • 7.12. Johnson & Johnson Services, Inc.
  • 7.13. Lupin Ltd.
  • 7.14. Mood Tracker Web Media, LLC
  • 7.15. Neuronetics, Inc.
  • 7.16. Otsuka Pharmaceutical Co., Ltd.
  • 7.17. Proteus Digital Health, Inc.
  • 7.18. Sunovion Pharmaceuticals Inc.

LIST OF TABLES

  • 1. GLOBAL BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL BIPOLAR DIORDER I MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL BIPOLAR DISORDER II MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL OTHER BIPOLAR DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 6. GLOBAL DRUGS & MEDICATIONS FOR BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL THERAPY & DEVICES/APPS FOR BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY MECHANISM OF ACTION, 2018-2025 ($ MILLION)
  • 9. GLOBAL SSRIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL SNRIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL BENZODIAZEPINES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL BETA BLOCKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBAL OTHER MECHANISM OF ACTION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBAL BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 15. NORTH AMERICAN BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 16. NORTH AMERICAN BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 17. NORTH AMERICAN BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 18. NORTH AMERICAN BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY MECHANISM OF ACTION, 2018-2025 ($ MILLION)
  • 19. EUROPEAN BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 20. EUROPEAN BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 21. EUROPEAN BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 22. EUROPEAN BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY MECHANISM OF ACTION, 2018-2025 ($ MILLION)
  • 23. ASIA-PACIFIC BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 24. ASIA-PACIFIC BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 25. ASIA-PACIFIC BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 26. ASIA-PACIFIC BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY MECHANISM OF ACTION, 2018-2025 ($ MILLION)
  • 27. REST OF THE WORLD BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
  • 28. REST OF THE WORLD BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
  • 29. REST OF THE WORLD BIPOLAR DISORDER MARKET RESEARCH AND ANALYSIS BY MECHANISM OF ACTION, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BIPOLAR DISORDER MARKET SHARE BY TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL BIPOLAR DISORDER MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)
  • 3. GLOBAL BIPOLAR DISORDER MARKET SHARE BY MECHANISM OF ACTION, 2018 VS 2025 (%)
  • 4. GLOBAL BIPOLAR DISORDER MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 5. USBIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. CANADA BIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. UKBIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. FRANCE BIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. GERMANY BIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ITALY BIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. SPAIN BIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. ROE BIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. INDIA BIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. CHINA BIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. JAPAN BIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC BIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)
  • 17. REST OF THE WORLD BIPOLAR DISORDER MARKET SIZE, 2018-2025 ($ MILLION)